Use of a traditional Chinese medicine composition based on Liyu Shengxian Tang in the preparation of a drug for treating lung nodules of qi deficiency and blood stasis type
By adjusting the formulation and preparation process of Liyu Shengxian Decoction, a traditional Chinese medicine composition honey pill suitable for pulmonary nodules of qi deficiency and blood stasis type was prepared, which solved the problem of the lack of traditional Chinese medicine solutions for directly treating pulmonary nodules of qi deficiency and blood stasis type in the existing technology and achieved significant therapeutic effects.
Patent Information
- Application Number
- CN202610629576.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-05-09
- Publication Date
- 2026-07-24
AI Technical Summary
In the existing technology, Liyu Shengxian Decoction is mainly used for conditioning and treatment of patients after pulmonary nodule resection. There are no reports of its direct application in the treatment of pulmonary nodules of qi deficiency and blood stasis type, and there is a lack of effective Chinese medicine treatment options.
The original formula of Liyu Shengxian Decoction was adjusted, omitting Anemarrhena asphodeloides and optimizing the dosage relationship of Astragalus membranaceus and Angelica sinensis. The traditional Chinese medicine composition was prepared by reflux extraction with a specific solvent and concentration and drying process to form a honey pill dosage form for the treatment of pulmonary nodules of qi deficiency and blood stasis type.
It significantly improved the treatment effect on pulmonary nodules of Qi deficiency and blood stasis type, and significantly increased the reduction rate of pulmonary nodules, providing a more effective Chinese medicine treatment plan.